Dr. Bostrom is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1477 N 2000 W
Ste C
Clearfield, UT 84015Phone+1 801-774-8888Fax+1 801-825-8519- Is this information wrong?
Education & Training
- University of Utah HealthResidency, Pediatrics, 1995 - 1998
- University of Utah HealthResidency, Peds/Psych/Child-Adolescent Psych, 1995 - 1996
- University of Florida College of MedicineInternship, Transitional Year, 1994 - 1995
- University of Florida College of MedicineClass of 1994
Certifications & Licensure
- UT State Medical License 1996 - 2026
- FL State Medical License 2008 - 2026
- American Board of Pediatrics Pediatrics
Clinical Trials
- Lurasidone Pediatric Autism Study Start of enrollment: 2013 Aug 01
- Pediatric Open-Label Extension Study Start of enrollment: 2013 Sep 30
- Lurasidone Pediatric Bipolar Study Start of enrollment: 2014 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.Pliszka, S. R.,Wilens, T. E.,Bostrom, S.,Arnold, V. K.,Marraffino, A.,Cutler, A. J.,López, F. A.,DeSousa, N. J.,Sallee, F. R.,Incledon, B.,Newcorn, J. H.> ;J Child Adolesc Psychopharmacol. 2017 Nov 28
Authored Content
- Effect of HLD200 on Caregiver-Reported ADHD Symptom Improvement in Children with ADHD and Caregiver Strain: Results from a Phase 3 TrialMay 2018
Hospital Affiliations
- McKay-Dee HospitalOgden, Utah
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: